Plunkett Research Online: Syros Pharmaceuticals

SYROS PHARMACEUTICALS (SYRS:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Syros Pharmaceuticals Inc is a biopharmaceutical company. The company is engaged in a non-coding regulatory region of the genome controlling the activation and repression of genes......



Syros Pharmaceuticals
Ticker: SYRS
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 1 617 744-1340
Fax:
Address: 620 Memorial Drive
Suite 300
Cambridge, MA 02139 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
ContactsDescription
Nancy SimonianCEO/Director/President
Joseph FerraCFO
See More
Syros Pharmaceuticals Inc is a biopharmaceutical company. The company is engaged in a non-coding regulatory region of the genome controlling the activation and repression of genes......See More See More

Auditor: Ernst & Young LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2017201620152014
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: